newsfilter
← Latest News
GlobeNewswire·

Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

  • Lexeo Therapeutics, Inc. (NASDAQ: LXEO) will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2026, at 2:35 p.m. ET in New York, NY.
  • The event will be webcast live under the News & Events tab in the Investors section of the Company's website, with a replay available on the Lexeo website following the presentation.
  • Lexeo Therapeutics is a New York City-based clinical stage genetic medicine company advancing therapeutic candidates targeting underlying genetic causes of cardiovascular diseases.
  • The company's portfolio includes LX2006 for Friedreich ataxia (FA) cardiomyopathy and LX2020 for plakophilin-2 (PKP2) arrhythmogenic cardiomyopathy.
  • Media inquiries should be directed to Media@lexeotx.com, while investor inquiries should be directed to Ashley Kaplowitz at akaplowitz@lexeotx.com.